|
Project
|
Collaborators
|
|
Annexin I in arthritis and inflammation
|
William Harvey Research Institute, London UK.
|
|
Biochemistry of 3(IV)NC1 and its role in autoimmunity
|
Prof Billy Hudson & Dr Dorin Bogdan-Borza, Vanderbilt University, Tennessee, USA
|
|
CD 39 in leucocyte adhesion
|
Prof Tony D’Apice, Immunology Research Centre St Vincent's Hospital, Melbourne
|
|
CD100 and other semaphorins in renal disease
|
Prof Hitoshi Kikutani, University of Osaka, Suita, Osaka, Japan
|
|
Duffy Antigen expression in haemoglobinopathy patients with chronic haemolysis
|
Dr. Ian Woolley, Department of Infectious Diseases, Monash Medical Centre
|
|
Early immune responses in sepsis
|
Prof Jack Cade & Dr. Christopher MacIsaac, Intensive Care Unit, Royal Melbourne Hospital
Dr. Chris Wright, Intensive Care Unit, Monash Medical Centre
|
|
HLA and Goodpasture’s disease
|
Prof Arthur Vandenbark VAMC Professor of Neurology , Oregon Health & Science University Portland, Oregan , USA
Prof Lars Fugger, Weatherall Institute of Molecular Medicine, University of Oxford, UK
|
|
IL-12/IL-23 in glomerulonephritis
|
Dr Daniel Cua, DNAX Research Institue, Palo Alto USA
|
|
IP-10 in immune renal disease
|
Prof Andrew Luster, Mass General, Boston, Mass, USA
|
|
The immunology of myeloperoxidase
|
Prof Aldons J Lusis, UCLA, Los Angeles, CA, USA
|
|
Innate immune function in mycobacterium infection
|
Dr. Grant Jenkin, Department of Infectious Diseases, Monash Medical Centre and Department of Microbiology, Monash Univeristy
Dr. Tim Stinear, Department of Microbiology, Monash University
|
|
Leucocytes in bronchiectasis
|
Dr Paul King, Department of Medicine, Monash University
|
|
The mechanisms of aberrant leukocyte trafficking in disease-affected organs
|
Dr. Daniel Bullard (University of Alabama at Birmingham)
|
|
The mechanisms of MIF-mediated recruitment of monocytes.
|
Dr Jurgen Bernhagen (University Hospital RWTH, Aachen, Germany)
|
|
MIF and angiogenesis in arthritis
|
University of Michigan, Ann Arbor Michigan USA
|
|
MIF and bone biology
|
University of Queensland
|
|
Molecular mechanisms of brain injury induced by cerebral ischemia
|
Dr Peter Crack, University of Melbourne
|
|
PAI-1 and diabetic renal disease
|
Prof Mark Cooper, Baker Institute, Melbourne
|
|
PD-L1 in glomerulonephritis
|
Prof Miyuki Azuma, Molecular Immunology, Tokyo Medical and Dental University
|
|
PD-1, PD-L2 in glomerulonephritis
|
Prof Hideo Yagida, Dept Immunology, Juntendo Univ, Toyko, Japan
|
|
RAGE and immune renal disease
|
Dr Josephine Forbes & Prof Mark Cooper, Baker Institute, Melbourne
|
|
The roles of chemokines & their receptors in mediating leukocyte recruitment in models of inflammation
|
Prof. Shaun McColl (University of Adelaide)
|
|
Role of innate immunity in chronic HBV infection
|
A/Prof Stephen Locarnini, Victorian Infectious Diseases Reference Laboratory
Prof Sharon Lewin, Infectious Diseases Unit, Alfred Hospital and Department of Medicine, Monash University
Dr. Michael Beard, Institute of Medicine and Veterinary Science, University of Adelaide
A/Prof Stephen Riordan, Gastrointestinal and Liver Unit, Prince of Wales Hospital
A/Prof Paul Desmond, Department of Gastroenterology, St Vincent’s Hospital
Prof Paul Hertzog & Dr. Ashley Mansell, Centre for Functional Genomics & Disease, MIMR
A/Prof William Sievert, Department of Gastroenterology, Monash Medical Centre
|
|
Small molecule MIF inhibitors as drug development candidates
|
Cortical Pty Ltd Australia.
|
|
Toll-like receptor autogeny during childhood
|
Dr. Winita Hardikar, Department of Gastroenterology, Royal Children’s Hospital, Melbourne
|
|
Toll-like receptors and pathogenesis of rotavirus infection
|
Dr Carl Kirkwood, Murdoch Children’s Research Institute
|
